Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611
This examiner grants 41% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18679898 | PURIFIED EXOSOME PRODUCTS, METHOD OF MAKING, AND METHODS OF USING | Final Rejection | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH |
| 18667002 | SKIN CARE SERUM COMPOSITION WITH NATURAL POLYMERS | Non-Final OA | The Procter & Gamble Company |
| 17422859 | ANTIBACTERIAL COMPOSITION | Non-Final OA | LG CHEM, LTD. |
| 18437576 | COMPOSITION FOR PHARMACEUTICAL TABLET, PHARMACEUTICAL TABLET USING THE SAME, AND MANUFACTURING METHOD THEREOF | Non-Final OA | Mitsubishi Chemical Corporation |
| 17905709 | ANTI-PATHOGEN STRUCTURE, METHOD FOR PRODUCING ANTI-PATHOGEN STRUCTURE, APPARATUS FOR PRODUCING ANTI-PATHOGEN STRUCTURE, AND LIQUID COMPOSITION | Non-Final OA | RICOH COMPANY, LTD. |
| 17273857 | METHOD OF PRODUCING METAL NANOPARTICLES AND USES THEREOF | Non-Final OA | RAMOT AT TEL-AVIV UNIVERSITY LTD. |
| 18001995 | PROTEIN TAG TO INDUCE LIGAND DEPENDENT DEGRADATION OF PROTEIN/PROTEIN-FUSIONS | Final Rejection | DANA-FARBER CANCER INSTITUTE, INC. |
| 18700612 | PLANT DISEASE RESISTANCE INDUCING METHOD, PLANT DISEASE RESISTANCE INDUCING DEVICE, AND PLANT DISEASE RESISTANCE INDUCING AGENT | Non-Final OA | TOHOKU UNIVERSITY |
| 18256655 | EXTRACT OF AT LEAST ONE PLANT OF THE CROCUS SATIVUS SPECIES COMPRISING A HIGH CONTENT OF CROCINS AND A LOW CONTENT OF SAFRANAL, AND COSMETIC USE THEREOF AS ANTIOXIDANT | Non-Final OA | L'OREAL |
| 18043142 | COMBINATION THERAPY OF A RAF INHIBITOR AND A MEK INHIBITOR FOR THE TREATMENT OF SARCOMA | Final Rejection | Board of Regents, The University of Texas System |
| 17609299 | COMPOSITION FOR PREVENTING OR TREATING INFLAMMATION, ALLERGIES AND ASTHMA, CONTAINING VERONICASTRUM SIBIRICUM L. PENNELL AS ACTIVE INGREDIENT, AND USE THEREOF | Final Rejection | KT&G CORPORATION |
| 18706889 | METHODS AND SYSTEMS FOR POINT-OF-CARE SYNTHESIS AND ADMINISTRATION OF PARTICLE-BASED THERAPEUTICS | Non-Final OA | Verily Life Sciences LLC |
| 18591613 | COSMETIC AEROSOL PRODUCT | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18765572 | LIPIDS AND USES THEREOF | Non-Final OA | TAIWAN BIO-MANUFACTURING CORPORATION |
| 18742224 | PHARMACEUTICAL COMPOSITION FOR IMPROVING HEALTH, CURE ABNORMALITIES AND DEGENERATIVE DISEASE, ACHIEVE ANTI-AGING EFFECT OF THERAPY AND THERAPEUTIC EFFECT ON MAMMALS AND METHOD THEREOF | Non-Final OA | Vector Vitale IP LLC |
| 18677559 | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEGENERATIVE DISEASES | Non-Final OA | Vector Vitale IP LLC |
| 17056797 | MICROBIAL MICROCAPSULE COMPOSITIONS, METHODS AND RELATED METHODS | Final Rejection | NEWLEAF SYMBIOTICS, INC. |
| 17989516 | OIL-BASED INSECTICIDAL AND INSECT REPELLENT COMPOSITIONS | Non-Final OA | S. C. Johnson & Son, Inc. |
| 18710264 | POLYMERSOMES FOR CLEARANCE OF AMYLOID BETA AND/OR TAU PROTEINS | Non-Final OA | West China Hospital, Sichuan University |
| 18648435 | PREPARATION METHOD FOR SEEDLING SUBSTRATE USING RESIDUES FROM POPULUS FORESTS AS RAW MATERIALS AND APPLICATION | Non-Final OA | Resarch Institute of Forestry Chinese Academy of Forestry |
| 18636428 | METHOD OF PREPARING STABLE, HIGH-LOAD, WATER-DISPERSIBLE LIPOSOMAL COMPOSITIONS THAT INCORPORATE WATER-INSOLUBLE THERAPEUTICS | Final Rejection | ESM Technologies, LLC |
| 18633246 | LIGHT-ACTIVATED CHLORINE DIOXIDE-RELEASING POWDER | Non-Final OA | PHIEX TECHNOLOGIES, INC. |
| 17927111 | COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING MICROBIAL INFECTIONS | Non-Final OA | University of Louisville Research Foundation, Inc. |
| 15551596 | COSMETIC PRODUCT COMPRISING A METAL CAN, AND THE CONTENTS OF SAME | Non-Final OA | BEIERSDORF AG |
| 18037611 | Texture-Controlled Fiber Ingredient Containing Viscous Soluble Fiber and Consumable Food and Fiber Supplement Products Incorporating Same | Non-Final OA | General Mills, Inc. |
| 17723155 | SUSTAINED-RELEASE MICROPARTICLES FOR SUSTAINED RELEASE OF DRUG | Non-Final OA | INVENTAGE LAB INC. |
| 18503177 | Treatment of Neurological Disorder Using NHR | Non-Final OA | Ocugen, Inc. |
| 17049882 | PIGMENT-LOADED SOLID LIPID NANOPARTICLES | Final Rejection | KØBENHAVNS UNIVERSITET |
| 18282410 | Use Of Honokiol In Preparation Of Drug For Treating Meningioma | Final Rejection | Chengdu Jinrui Foundation Biotech Co., Ltd. |
| 17767783 | COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO CELLS | Non-Final OA | University of Maryland, Baltimore |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy